Between 2017 and 2021, private investors put nearly $29 billion into healthcare AI worldwide, more than in any other sector.
This increase shows more people believe AI can help doctors make decisions, automate office work, and customize care for patients.
Over 900 AI medical devices got FDA approval, including software tools, diagnostic devices, and communication systems in healthcare.
Even with these advances, current rules like the FDA’s 510(k) clearance and HIPAA were made long ago and do not fully fit modern AI technology.
The FDA clearance process started in 1976 and was mostly for physical devices, not software that learns and adapts on its own.
Because of this, most AI medical devices are grouped as moderate-risk Class II, but this does not show the full range of risks AI can have in healthcare.
Medical administrators and IT managers in the US must deal with this unclear regulation while making sure AI tools meet federal standards and keep patients safe.
It is important to understand the challenges connected to AI independence, control, and rules.
Fully autonomous AI, sometimes called agentic AI, can think, plan, and do complicated tasks mostly on its own.
Unlike usual AI that just answers questions, agentic AI keeps working by setting goals, planning, acting, watching results, and changing plans.
In healthcare, these systems can use many data sources, connect with health records, schedule appointments, and handle parts of the workflow.
By automating these tasks, agentic AI may help make operations faster and easier to scale.
For example, AI agents can manage scheduling, approvals, or medical paperwork without people needing to check every step.
But using such systems has limits, especially in healthcare where safety and responsibility are very important.
Challenges include:
Because of these problems, fully autonomous AI is usually used in limited situations where humans still review important decisions.
Human-in-the-loop (HiTL) means humans help make important decisions inside an AI system.
Experts check, fix, or stop AI outputs when needed.
This method is common and safer in healthcare because:
Human reviewers do tasks like labeling data for training AI, checking uncertain AI results, and giving feedback so AI can improve over time with reinforcement learning.
Although HiTL systems help, they also have some problems that healthcare managers should know:
Managers and IT staff must think about where HiTL works best, especially for high-risk or sensitive uses like mental health chatbots or diagnostic tools that interact with patients.
Rules for AI in healthcare are still developing.
Current US laws are behind fast technology changes.
Policymakers, researchers, healthcare workers, and developers recently met at Stanford Institute for Human-Centered AI to discuss the issues.
They agreed that existing rules like FDA device clearance and HIPAA were not designed for software AI tools, making it hard to follow the laws.
Some ideas to improve regulations include:
Regulatory problems are especially big for AI that talks to patients, like mental health chatbots, which might give wrong or harmful advice without clear medical supervision.
Besides helping with medical decisions, AI has improved front-office tasks.
Automated phone systems and AI answering services help manage patient calls, scheduling, and answering questions.
Companies like Simbo AI offer AI phone automation to make patient access easier and reduce office workload.
Hospital leaders and practice managers can use AI automation to:
Simbo AI’s phone automation shows how AI can help run offices more smoothly while focusing on patient service.
Agentic AI means autonomous agents that can set goals, plan, and carry out many steps on their own.
These systems change plans as needed and work across clinical and administrative parts of healthcare.
Most experts agree it is important to keep humans involved.
They suggest models with layers of human control:
This step-by-step method helps balance AI benefits with safety, rules, and ethics.
Tools called explainable AI (XAI) help make AI clearer.
Organizations planning to use agentic AI should prepare infrastructure, change workflows, and set rules to avoid errors.
Policies should say who owns tasks, when to stop AI work, and how to audit results.
Healthcare managers and IT staff in the US face key choices when using AI:
Balancing AI independence and human oversight can help US healthcare improve patient results, run better, and keep patients happy while managing AI risks.
Using AI in healthcare brings new chances and challenges, especially about how much AI should act alone and how much humans should watch.
Fully autonomous AI is growing fast but needs close supervision because it can be hard to understand and responsible decisions must be ensured.
Human-in-the-loop methods remain important for accuracy, ethics, and following rules in high-risk healthcare work.
Healthcare leaders and IT teams in the US must learn what AI can and cannot do, invest in human oversight, and match AI use to patient safety and organizational goals.
Companies like Simbo AI show how AI can help with office tasks, offering clear ways to improve efficiency now.
As AI gets better and laws change, success will come from using AI to support human knowledge and choices, not replace them.
Key ethical concerns include patient safety, harmful biases, data security, transparency of AI algorithms, accountability for clinical decisions, and ensuring equitable access to AI technologies without exacerbating health disparities.
Current regulations like the FDA’s device clearance process and HIPAA were designed for physical devices and analog data, not complex, evolving AI software that relies on vast training data and continuous updates, creating gaps in effective oversight and safety assurance.
Streamlining market approval through public-private partnerships, enhancing information sharing on test data and device performance, and introducing finer risk categories tailored to the potential clinical impact of each AI function are proposed strategies.
Opinions differ; some advocate for human-in-the-loop to maintain safety and reliability, while others argue full autonomy may reduce administrative burden and improve efficiency. Hybrid models with physician oversight and quality checks are seen as promising compromises.
Developers should share detailed information about AI model design, functionality, risks, and performance—potentially through ‘model cards’—to enable informed decisions about AI adoption and safe clinical use.
In some cases, especially patient-facing interactions or automated communications, patients should be informed about AI involvement to ensure trust and understanding, while clinical decisions may be delegated to healthcare professionals’ discretion.
There is a lack of clear regulatory status for these tools, which might deliver misleading or harmful advice without medical oversight. Determining whether to regulate them as medical devices or healthcare professionals remains contentious.
Engaging patients throughout AI design, deployment, and regulation helps ensure tools meet diverse needs, build trust, and address or avoid worsening health disparities within varied populations.
They provide ongoing monitoring of AI tool performance in real-world settings, allowing timely detection of safety issues and facilitating transparency between developers and healthcare providers to uphold clinical safety standards.
Multidisciplinary research, multistakeholder dialogue, updated and flexible regulatory frameworks, and patient-inclusive policies are essential to balance innovation with safety, fairness, and equitable healthcare delivery through AI technologies.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
